1
Clinical Trials associated with Mesenchymal stromal cell-based therapy(DOr Institute for Research and Education)Mesenchymal Stromal Cell-based Therapy for COVID-19-associated Acute Respiratory Distress Syndrome: a Pilot Clinical Study
Considering the potential of mesenchymal stromal cells (MSCs) in the treatment of lung injuries by COVID-19, this pilot clinical trial evaluates the safety and potential efficacy of the cell therapy, administered intravenously, in patients with pneumonia associated with COVID-19-associated acute respiratory distress syndrome.
100 Clinical Results associated with Mesenchymal stromal cell-based therapy(DOr Institute for Research and Education)
100 Translational Medicine associated with Mesenchymal stromal cell-based therapy(DOr Institute for Research and Education)
100 Patents (Medical) associated with Mesenchymal stromal cell-based therapy(DOr Institute for Research and Education)
100 Deals associated with Mesenchymal stromal cell-based therapy(DOr Institute for Research and Education)